top of page

Lesestoff für Impfärzte

Es ist wohl zuviel verlangt, dass Ärzte, die ihre Patienten mit den experimentellen Genimpfstoffen behandeln, sich selbstständig über die Risiken informieren. Man kann ihnen aber gezielt Lektüre empfehlen. Hier eine Auswahl der mittlerweile sehr umfangreichen wissenschaftlichen Literatur zur Gefährlichkeit von Spike-Protein, Nanopartikeln, PEG, CPG und Vektorviren. Wer sich übrigens weigert zu lesen oder es nicht kann - sollte auch nicht impfen.

SCHEIERMANN, J. & KLINMAN, D. M. 2014. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. Vaccine, 32, 6377-6389.

MULLEN, G. E. D., ELLIS, R. D., MIURA, K., MALKIN, E., NOLAN, C., HAY, M., FAY, M. P., SAUL, A., ZHU, D., RAUSCH, K., MORETZ, S., ZHOU, H., LONG, C. A., MILLER, L. H. & TREANOR, J. 2008. Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. PLOS ONE, 3, e2940.

BROCK, A. S., THORNLEY 2021. Rapid Communication

Spontaneous Abortions and Policies on COVID-19 mRNA Vaccine Use During Pregnancy. An Institute for Pure

and Applied Knowledge (IPAK): An Institute for Pure

and Applied Knowledge (IPAK).

DOSHI, P. 2021. Does the FDA think these data justify the first full approval of a covid-19 vaccine? BMJ

EMA (2021) ‚EudraVigilance-European database of suspected adverse drug reaction reports‘, Available: (Accessed 10.11.2021).

OLAJIDE, O. A., IWUANYANWU, V. U., ADEGBOLA, O. D. & AL-HINDAWI, A. A. 2021. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia. Molecular Neurobiology.

LISEWSKI, A. M. 2020. Association between influenza vaccination rates and SARS-CoV-2 outbreak infection rates in OECD countries. Available at SSRN 3558270.

RIKIN, S., JIA, H., VARGAS, C. Y., CASTELLANOS DE BELLIARD, Y., REED, C., LARUSSA, P., LARSON, E. L., SAIMAN, L. & STOCKWELL, M. S. 2018. Assessment of temporally-related acute respiratory illness following influenza vaccination. Vaccine, 36, 1958-1964.

COWLING, B. J., FANG, V. J., NISHIURA, H., CHAN, K.-H., NG, S., IP, D. K. M., CHIU, S. S., LEUNG, G. M. & PEIRIS, J. S. M. 2012. Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine. Clinical Infectious Diseases, 54, 1778-1783.

WOLFF, G. G. 2020. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season. Vaccine, 38, 350-354.

GAZIT, S., SHLEZINGER, R., PEREZ, G., LOTAN, R., PERETZ, A., BEN-TOV, A., COHEN, D., MUHSEN, K., CHODICK, G. & PATALON, T. 2021. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv, 2021.08.24.21262415.

CARDOZO, T. & VEAZEY, R. 2021. Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease. International journal of clinical practice, 75, e13795.

KELLENI, M. 2021. Potential Autoimmunity or Antibody Dependent COVID-19 Enhancement of SARS CoV-2 Vaccination or Convalescent Plasma: A Potential Man-Made Hades.

FARSHI, E. 2020. Cytokine Storm Response to COVID-19 Vaccinations. J Cytokine Biol, 5, 2.

RICKE, D. O. 2021. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Frontiers in Immunology, 12, 443.

PETRUK, G., PUTHIA, M., PETRLOVA, J., SAMSUDIN, F., STRÖMDAHL, A.-C., CERPS, S., ULLER, L., KJELLSTRÖM, S., BOND, P. J., SCHMIDTCHEN & ARTUR 2020. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. Journal of Molecular Cell Biology, 12, 916-932.

LI, F., LI, J., WANG, P.-H., YANG, N., HUANG, J., OU, J., XU, T., ZHAO, X., LIU, T., HUANG, X., WANG, Q., LI, M., YANG, L., LIN, Y., CAI, Y., CHEN, H. & ZHANG, Q. 2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1867, 166260.

HSU, A. C.-Y., WANG, G., REID, A. T., VEERATI, P. C., PATHINAYAKE, P. S., DALY, K., MAYALL, J. R., HANSBRO, P. M., HORVAT, J. C., WANG, F. & WARK, P. A. 2020. SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors <em>in vitro</em>. bioRxiv, 2020.09.30.317818.

SHIRATO, K. & KIZAKI, T. 2021. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon, 7, e06187.

SKIBA, M. A. & KRUSE, A. C. 2020. Autoantibodies as endogenous modulators of GPCR signaling. Trends in Pharmacological Sciences.

KERR, J. R. 2019. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. Journal of Clinical Pathology, 72, 651-658.

BROCK, A. S., THORNLEY 2021. Spontaneous Abortions and Policies on COVID-19 mRNA Vaccine Use During Pregnancy. Science, Public Health Policy, and the Law, 4:130-143.

CHIU, H.-H., WEI, K.-C., CHEN, A. & WANG, W.-H. 2021. Herpes zoster following COVID-19 vaccine: a report of three cases. QJM: An International Journal of Medicine, 114, 531-532.

UK-HEALTH-SECURITY-AGENCY (2021) ‚Covid-19 vaccine surveillance report week 42‘, Available: (Accessed 10.11.2021).

JIANG, H. & MEI, Y.-F. 2021. SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V (D) J Recombination In Vitro. Viruses, 13, 2056.

SAAD, M. H., BADIERAH, R., REDWAN, E. M. & EL-FAKHARANY, E. M. 2021. A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions. Pharmaceutics, 13, 1405.

BANSAL, S., PERINCHERI, S., FLEMING, T., POULSON, C., TIFFANY, B., BREMNER, R. M. & MOHANAKUMAR, T. 2021. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. The Journal of Immunology, 207, 2405-2410.

TAIWAN-NEWS (2021) ‚Taiwan halts 2nd-dose BioNTech vaccinations for ages 12-17 amid concerns of myocarditis | Taiwan News | 2021-11-10 15:42:00‘, Available: (Accessed).

STEIN, A. (2021) ‚Die Gesamtsterblichkeit scheint sich 2021 zu erhöhen – Effekt der Impfkampagne? Großes Update 10.11.2021‘, [Online]. Available: (Accessed 13.11.2021).

CLASSEN, B. US COVID-19 Vaccines Proven to Cause More Harm than Good Based on Pivotal Clinical Trial Data Analyzed Using the Proper Scientific Endpoint,“All Cause Severe Morbidity”. Trends Int Med. 2021; 1 (1): 1-6. Correspondence: J. Bart Classen, MD, Classen Immunotherapies, Inc, 3637.

KIRSCH, S. 2021. Hace Covid vaccines killed 200.000 Americans? FDA. Covid-19 Early treatment fund.

KOSTOFF, R. N., KANDUC, D., PORTER, A. L., SHOENFELD, Y., CALINA, D., BRIGGS, M. B., SPANDIDOS, D. A. & TSATSAKIS, A. 2020. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicology Reports, 7, 1448-1458.

DUTTA, S. & SENGUPTA, P. 2020. SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out? Journal of Basic and Clinical Physiology and Pharmacology, 31.